TRANSCEND Cancer Initiative

The TRANSCEND Cancer Initiative (TCI) is a TRANSlational researCh incubator for the trEatment, interceptioN, anD prevention of cancer.

TRANSCEND provides critical resources for translational research and networking opportunities for investigators in the division of surgery to facilitate high-impact translational research studies across disease-sites and to facilitate a team science network that will accelerate discoveries and innovation to treat, intercept, and ultimately prevent cancer.

The TCI facilitates interactions with existing platforms and institutes (Cancer Genomics Laboratory, Translational Molecular Pathology, Institute for Personalized Cancer Therapy, Immunotherapy Platform, Cancer Control and Prevention, Integrative Medicine, the Program for Innovative Microbiome and Translational Research – PRIME-TR, and others) and provides key resources to integrate and learn from diverse data sets (genomic and immune profiling, digital spatial profiling, among other cutting-edge profiling strategies). TCI also has shared resources for immune profiling and other analyses that are available to TCI investigators. The initiative works with investigators and Strategic Industry Ventures to maximize and translate insights gained, including industry-sponsored translational clinical trials.